Intravesical versus intravesical plus intradermal bacillus Calmette-Guerin: A prospective randomized study in patients with recurrent superficial bladder tumors

Journal of Urology

Volumn 155, Issue 2, 1996, Pages 483-487

  Lüftenegger, Werner ^a   Ackermann, Daniel K ^a   Futterlieb, Andrea ^a   Kraft, Rainer ^a   Minder, Christoph E ^a   Nadelhaft, Peter ^a   Studer, Urs E ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Administration, cutaneous; Administration, intravesical; BCG vaccine; Bladder neoplasms

Indexed keywords

BCG VACCINE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INTRADERMAL DRUG ADMINISTRATION; INTRAVESICAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; REGIONAL PERFUSION; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0030066847     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66427-9     Document Type: Article

References (15)

1. Ratliff, T. L., Ritchey, J. K., Yuan, J. J. J., Andriole, G. L. and Catalona, W. J.: T-cell subsets required for intravesical BCG immunotherapy for bladder cancer. J. Urol., 150: 1018, 1993.
2. deKernion, J. B., Huang, M.-Y., Lindner, A., Smith, R. B. and Kaufmann, J. J.: The management of superficial bladder tumors and carcinoma in situ with intravesical bacillus Calmette-Guerin. J. Urol., 133: 598, 1985.
3. D'Ancona, C. A. L., Netto, N. R., Jr., Claro, J. A. and Ikari, O.: Oral or intravesical bacillus Calmette-Guerin immunoprophylaxis in bladder cancer. J. Urol., 145: 498, 1991.
4. Lamm, D. L.: Bacillus Calmette-Guerin immunotherapy for bladder cancer. J. Urol., 134: 40, 1985.
5. Khanna, O. P., Son, D. L., Mazer, H., Read, J., Nugent, D., Cottone, R., Heeg, M., Rezvan, M., Viek, N., Uhlman, R. and Friedmann, M.: Multicenter study of superficial bladder cancer treated with intravesical bacillus Calmette-Guérin or adriamycin. Urology, 35: 101, 1990.
6. Herr, H. W., Pinsky, C. M., Whitmore, W. F., Jr., Sogani, P. C., Oettgen, H. F. and Melamed, M. R.: Long-term effect of intravesical bacillus Calmette-Guerin on flat carcinoma in situ of the bladder. J. Urol., 135: 265, 1986.
7. Lamm, D. L., DeHaven, J. I., Shriver, J. and Sarosdy, M. F.: Prospective randomized comparison of intravesical with percutaneous bacillus Calmette-Guerin versus intravesical bacillus Calmette-Guerin in superficial bladder cancer. J. Urol., 145: 738, 1991.
8. Kelley, D. R., Haaff, E. O., Becich, M., Lage, J., Bauer, W. C., Dresner, S. M., Catalona, W. J. and Ratliff, T. L.: Prognostic value of purified protein derivative skin test and granuloma formation in patients treated with intravesical bacillus Calmette-Guerin. J. Urol., 135: 268, 1986.
9. Torrence, R. J., Kavoussi, L. R., Catalona, W. J. and Ratliff, T. L.: Prognostic factors in patients treated with intravesical bacillus Calmette-Guerin for superficial bladder cancer. J. Urol., 139: 941, 1988.
10. Morales, A. and Nickel, J. C.: Immunotherapy of superficial bladder cancer with BCG. World J. Urol., 3: 209, 1986.
11. Harrison's Principles of Internal Medicine, 11th ed. Edited by E. Braunwald, K. J. Isselbacher, R. G. Petersdorf, J. D. Wilson, J. B. Martin and A. S. Fauci. New York: McGraw-Hill Book Co., 1987.
12. Mandell, G. L., Douglas, R. G. and Bennett, J. E.: Mycobacterium tuberculosis. In: Principles and Practice of Infectious Diseases, 4th ed. Edited by G. L. Mandell, J. E. Bennett and R. Dolin. New York: Churchill Livingstone, chapt. 230, p. 2219, 1995.
13. Merz, V. W., Marth, D., Kraft, R., Ackermann, D. K., Zingg, E. J. and Studer, U. E.: Analysis of early failures after intravesical instillation therapy with bacille Calmette-Guérin for carcinoma in situ of the bladder. Brit. J. Urol., 75: 180, 1995.
14. Lamm, D. L., Crawford, E. D., Blumenstein, B., Crissman, J. D., Montie, J., Gottesman, J., Lowe, B., Sarosdy, M. F., Bohl, R. D., Weems, W. L., Grossman, H. B., Smith, J. A., Beck, T. M., Leimert, J. and Coltman, C. A.: Maintenance BCG immunotherapy of superficial bladder cancer: a randomized prospective Southwest Oncology Group study. J. Urol., part 2, 147: 274A, abstract 242, 1992.
15. Lamm, D. L., van der Meijden, A. P. M., Morales, A., Brosman, S. A., Catalona, W. J., Herr, H. W., Soloway, M. S., Steg, A. and Debruyne, F. M. J.: Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J. Urol., 147: 596, 1992.